Hepatobiliary cancer biomarkers
3 European H2020 organizations list this as part of their work — 1 as their primary capability.
Most active in this area
- UNIVERSIDAD SAN FRANCISCO DE QUITO
Ecuadorian university bridging Latin American research into EU projects across health, biodiversity, and nanotechnology sensing.
“ESCALON project focused on predictive and diagnostic biomarkers for liver cancer, hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma across European-Latin American populations.”
EC4 projects - THE CHRISTIE NHS FOUNDATION TRUST
Major UK cancer hospital contributing proton beam therapy expertise, clinical trial capacity, and cancer biomarker research to international consortia.
“ESCALON focuses on predictive and diagnostic biomarkers for liver cancer, cholangiocarcinoma, and gallbladder carcinoma.”
UK3 projects - UNIVERSIDAD SAN MARTIN DE PORRES ASOCIACION
Peruvian university providing Latin American clinical expertise in cancer biomarkers, diabetes, and aging research for EU-LATAM health consortia.
“ESCALON focuses on predictive and diagnostic biomarkers for hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma.”
PrimaryPE3 projects